VTRS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's ...

VTRS stock has a consensus “Hold” rating overall ... On Dec. 6, Piper Sandler Companies (PIPR) raised Viatris' price target to $14 from $13 while maintaining a “Neutral” rating.

Davis Selected Advisers' 13F portfolio saw changes with stake increases in tech and travel, while reducing in financial and ...

A price to sales ("P/S") ratio of <1x is ... Analyst’s Disclosure: I/we have a beneficial long position in the shares of VTRS either through stock ownership, options, or other derivatives.

Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...